Sulfisomidine
From Wikipedia, the free encyclopedia
|
Sulfisomidine
|
|
| Systematic (IUPAC) name | |
| 4-amino-N-(2,6-dimethylpyrimidin-4-yl) benzenesulfonamide |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C12H14N4O2S |
| Mol. mass | 278.331 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Minor acetylation |
| Half life | ? |
| Excretion | Renal, 85% |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Sulfisomidine (INN), also known as sulphasomidine (BAN until 2003),[1] sulfamethin and sulfaisodimidine, is a sulfonamide antibacterial. It is closely related to sulfadimidine.
[edit] References
- ^ Changing substance names from BANs to rINNs.PDF (34.5 KiB). United Kingdom Medicines and Healthcare products Regulatory Agency (December 12, 2003). Retrieved on 2007-08-26 through Archive.org.
[edit] External links
- Melander A, Bitzén PO, Olsson S (1982). "Therapeutic equivalence of sulfaisodimidine 2 g twice daily and 1 g four times daily in lower urinary tract infections". Acta medica Scandinavica 211 (5): 361-4. PMID 7051761.
|
||||||||||||||||||||

